These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 21483109)
21. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Kay DM; Zabetian CP; Factor SA; Nutt JG; Samii A; Griffith A; Bird TD; Kramer P; Higgins DS; Payami H Mov Disord; 2006 Apr; 21(4):519-23. PubMed ID: 16250030 [TBL] [Abstract][Full Text] [Related]
22. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease. Infante J; Rodríguez E; Combarros O; Mateo I; Fontalba A; Pascual J; Oterino A; Polo JM; Leno C; Berciano J Neurosci Lett; 2006 Mar; 395(3):224-6. PubMed ID: 16298482 [TBL] [Abstract][Full Text] [Related]
23. LRRK2 mutations are a common cause of Parkinson's disease in Spain. Mata IF; Ross OA; Kachergus J; Huerta C; Ribacoba R; Moris G; Blazquez M; Guisasola LM; Salvador C; Martinez C; Farrer M; Alvarez V Eur J Neurol; 2006 Apr; 13(4):391-4. PubMed ID: 16643318 [TBL] [Abstract][Full Text] [Related]
24. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease. Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients. Duque AF; Lopez JC; Benitez B; Hernandez H; Yunis JJ; Fernandez W; Arboleda H; Arboleda G Colomb Med (Cali); 2015 Sep; 46(3):117-21. PubMed ID: 26600626 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain. Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361 [TBL] [Abstract][Full Text] [Related]
27. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease. Patra B; Parsian AJ; Racette BA; Zhao JH; Perlmutter JS; Parsian A Parkinsonism Relat Disord; 2009 Mar; 15(3):175-80. PubMed ID: 18752982 [TBL] [Abstract][Full Text] [Related]
28. G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia. Pchelina SN; Yakimovskii AF; Ivanova ON; Emelianov AK; Zakharchuk AH; Schwarzman AL Mov Disord; 2006 Dec; 21(12):2234-6. PubMed ID: 17044089 [TBL] [Abstract][Full Text] [Related]
29. A study of LRRK2 mutations and Parkinson's disease in Brazil. Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824 [TBL] [Abstract][Full Text] [Related]
30. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews. Thaler A; Ash E; Gan-Or Z; Orr-Urtreger A; Giladi N J Neural Transm (Vienna); 2009 Nov; 116(11):1473-82. PubMed ID: 19756366 [TBL] [Abstract][Full Text] [Related]
31. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal. Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194 [TBL] [Abstract][Full Text] [Related]
32. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study. Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881 [TBL] [Abstract][Full Text] [Related]
33. MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease. White LR; Toft M; Kvam SN; Farrer MJ; Aasly JO J Neurosci Res; 2007 May; 85(6):1288-94. PubMed ID: 17385669 [TBL] [Abstract][Full Text] [Related]
34. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. Marongiu R; Ghezzi D; Ialongo T; Soleti F; Elia A; Cavone S; Albanese A; Altavista MC; Barone P; Brusa L; Cortelli P; Petrozzi L; Scaglione C; Stanzione P; Tinazzi M; Zeviani M; Dallapiccola B; Bentivoglio AR; Valente EM; Garavaglia B; Mov Disord; 2006 Aug; 21(8):1232-5. PubMed ID: 16622859 [TBL] [Abstract][Full Text] [Related]
35. Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease. Squillaro T; Cambi F; Ciacci G; Rossi S; Ulivelli M; Malandrini A; Mencarelli MA; Mari F; Renieri A; Ariani F J Hum Genet; 2007; 52(3):201-204. PubMed ID: 17235449 [TBL] [Abstract][Full Text] [Related]
36. Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease. Lesage S; Leclere L; Lohmann E; Borg M; Ruberg M; Dürr A; Brice A; Neurodegener Dis; 2007; 4(2-3):195-8. PubMed ID: 17596714 [TBL] [Abstract][Full Text] [Related]
37. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation. Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768 [TBL] [Abstract][Full Text] [Related]
38. The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's disease. Möller JC; Rissling I; Mylius V; Höft C; Eggert KM; Oertel WH Eur J Neurol; 2008 Jul; 15(7):743-5. PubMed ID: 18484993 [TBL] [Abstract][Full Text] [Related]
39. Genetic analysis of LRRK2 mutations in patients with Parkinson disease. Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110 [TBL] [Abstract][Full Text] [Related]
40. [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population]. Shadrina MI; Illarioshkin SN; Bagyeva GKh; Bespalova EV; Zagorodskaia TB; Slominskiĭ PA; Markova ED; Kliushnikov SA; Limborskaia SA; Ivanova-Smolenskaia IA Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):46-50. PubMed ID: 18379513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]